The importance of launching the national external quality assessment of 1-3-β-D-glucan test and galactomannan antigen test
10.3760/cma.j.cn114452-20240205-00070
- VernacularTitle:开展1-3-β-D-葡聚糖试验和半乳甘露聚糖抗原试验全国室间质评的重要性
- Author:
Yaya PIAN
1
;
Jihong HU
;
Yudong LIU
Author Information
1. 北京医院 国家老年医学中心 国家卫生健康委临床检验中心 中国医学科学院老年医学研究院，北京100730
- Keywords:
External quality assessment;
Infectious disease;
β-D-glucan test;
Galactomannan antigen test
- From:
Chinese Journal of Laboratory Medicine
2024;47(9):999-1004
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of invasive fungal diseases has been increasing annually, becoming one of the most serious infectious diseases affecting clinical departments. Currently, the primary indicators for early diagnosis of invasive fungal disease are the 1-3-β-D-glucan test and the galactomannan antigen test, known as the G test and GM test, respectively. The National Health Commission of the People′s Republic of China, in Goal Four of the'National Medical Quality and Safety Improvement Goals′, proposed to'increase the submission rate of pathogen examination before antibiotic treatment in hospitalized patients′, and emphasized the importance of tests such as G test as common clinical mycological diagnostic tools. Moreover, it is of paramount significance for clinical laboratories to ensure the quality of fungal detection. This paper provides a detailed discussion of the key factors affecting the G test and GM test, and the importance of launching the national external quality assessments.
